Cited by 2,020Schizophrenia research and treatmentNeurotransmitter Receptor Influence on BehaviorMental Health and Psychiatry

The DOI matches its Crossref record; 398 of the 399 references it cites were found in a registry or an index.

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

Harrison, P J, Weinberger, D R·2005·Molecular Psychiatry

DOI 10.1038/sj.mp.4001558

Open this paper in CoChat — free account

Abstract

This review critically summarizes the neuropathology and genetics of schizophrenia, the relationship between them, and speculates on their functional convergence. The morphological correlates of schizophrenia are subtle, and range from a slight reduction in brain size to localized alterations in the morphology and molecular composition of specific neuronal, synaptic, and glial populations in the hippocampus, dorsolateral prefrontal cortex, and dorsal thalamus. These findings have fostered the view of schizophrenia as a disorder of connectivity and of the synapse. Although attractive, such concepts are vague, and differentiating primary events from epiphenomena has been difficult. A way forward is provided by the recent identification of several putative susceptibility genes (including neuregulin, dysbindin, COMT, DISC1, RGS4, GRM3, and G72). We discuss the evidence for these and other genes, along with what is known of their expression profiles and biological roles in brain and how these may be altered in schizophrenia. The evidence for several of the genes is now strong. However, for none, with the likely exception of COMT, has a causative allele or the mechanism by which it predisposes to schizophrenia been identified. Nevertheless, we speculate that the genes may all converge functionally upon schizophrenia risk via an influence upon synaptic plasticity and the development and stabilization of cortical microcircuitry. NMDA receptor-mediated glutamate transmission may be especially implicated, though there are also direct and indirect links to dopamine and GABA signalling. Hence, there is a correspondence between the putative roles of the genes at the molecular and synaptic levels and the existing understanding of the disorder at the neural systems level. Characterization of a core molecular pathway and a 'genetic cytoarchitecture' would be a profound advance in understanding schizophrenia, and may have equally significant therapeutic implications.

Integrity signals

Registry

Crossref · 10.1038/sj.mp.4001558

Cites

398 of 398 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals
Jaenisch, R., & Bird, A. (2003) · Nature Genetics · doi:10.1038/ng1089 · Cited by 6,325
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724
Self-citation
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
Amyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538
Effect of COMT Val 108/158 Met genotype on frontal lobe function and risk for schizophrenia
Egan, M. F., Goldberg, T. E., Kolachana, B. S., Callicott, J. H., Mazzanti, C. M., Straub, R. E., Goldman, D. A., & Weinberger, D. R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111134598 · Cited by 2,416
Self-citation
Schizophrenia as a Complex Trait: Evidence From a Meta-analysis of Twin Studies
Sullivan, P. F., Kendler, K. S., & Neale, M. C. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.12.1187 · Cited by 2,356
A review of MRI findings in schizophrenia
Shenton, M. E., Dickey, C. C., Frumin, M., & McCarley, R. W. (2001) · Schizophrenia Research · doi:10.1016/s0920-9964(01)00163-3 · Cited by 2,346
Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease
Lohmueller, K. E., Pearce, C. L., Pike, M., Lander, E. S., & Hirschhorn, J. N. (2003) · Nature Genetics · doi:10.1038/ng1071 · Cited by 1,900
Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders
Lachman, H. M., Papolos, D. F., Saito, T., Yu, Y.-M., Szumlanski, C. L., & Weinshilboum, R. M. (1996) · Pharmacogenetics · doi:10.1097/00008571-199606000-00007 · Cited by 1,788

Flagged first, then by citations

Show all 399 references

1 of the 399 references couldn’t be matched to a known paper.

Research works printed but not linked: 4

Grossman MH, Littrel JB, Weinstein R, Szumlanski C, Weinshilboum R . Identification of the possible basis for inherited differences in human catechol-O-methyltransferase. Trans Neurosci Soc 1992; 18: 70.
Straub RE, Egan MF, Hashimoto R, Matsumoto M, Weickert CS, Goldberg T et al. The schizophrenia susceptibility gene dysbindin (DTNBP1, 6p22.3): analysis of haplotypes, intermediate phenotypes, and alternative transcripts. Biol Psychiatry 2003; 53: 167S.
Callicott JH, Pezeawas L, Egan MF, Hariri AR, Mattay VS, Goldberg TE et al. Genetic variationVariation in DISC-1 affects hippocampal structure and function associated with increased risk for schizophrenia and with normal hippocampal structure and function. (in review).
Toro CT, Kasher PR, Deakin JFW . Altered D-serine metabolism in schizophrenia? A post-mortem study using Stanley Consortium brains [Abstract]. Schizophr Res 2004; 67(Suppl): 125.

Sorted by citations

Items 601–700 of 1,003

A meta-analysis of ultra-high field glutamate, glutamine, GABA and glutathione 1HMRS in psychosis: Implications for studies of psychosis risk
Sydnor, V. J., & Roalf, D. R. (2020) · Schizophrenia Research · doi:10.1016/j.schres.2020.06.028 · Cited by 68
Prefrontal Electrophysiologic “Noise” and Catechol-O-Methyltransferase Genotype in Schizophrenia
Winterer, G., Egan, M. F., Kolachana, B. S., Goldberg, T. E., Coppola, R., & Weinberger, D. R. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.023 · Cited by 69
Self-citation
Approaching a network connectivity-driven classification of the psychosis continuum: a selective review and suggestions for future research
Schmidt, A., Diwadkar, V. A., Smieskova, R., Harrisberger, F., Lang, U. E., McGuire, P. K., Fusar‐Poli, P., & Borgwardt, S. (2015) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2014.01047 · Cited by 73
PRODH variants and risk for schizophrenia
Willis, A. S., Bender, H., Steel, G., & Valle, D. L. (2008) · Amino Acids · doi:10.1007/s00726-008-0111-0 · Cited by 68
The role of cerebellar genes in pathology of autism and schizophrenia
Fatemi, S. H., Reutiman, T. J., Folsom, T. D., & Sidwell, R. W. (2008) · The Cerebellum · doi:10.1007/s12311-008-0017-0 · Cited by 68
Increased water diffusivity in the frontal and temporal cortices of schizophrenic patients
Shin, Y., Kwon, J. S., Ha, T. H., Park, H., Kim, D. J., Hong, S., Moon, W., Lee, J. M., Kim, I. Y., Kim, S. I., et al. (2006) · NeuroImage · doi:10.1016/j.neuroimage.2005.11.017 · Cited by 68
ErbB4 Genotype Predicts Left Frontotemporal Structural Connectivity in Human Brain
Konrad, A., Vučurević, G., Musso, F., Stoeter, P., Dahmen, N., & Winterer, G. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.112 · Cited by 69
Subchronic Phencyclidine Treatment Decreases the Number of Dendritic Spine Synapses in the Rat Prefrontal Cortex
Hajszán, T., Léránth, C., & Roth, R. H. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.015 · Cited by 68
Substance use disorders and schizophrenia: A question of shared glutamatergic mechanisms
Coyle, J. T. (2006) · Neurotoxicity Research · doi:10.1007/bf03033359 · Cited by 71
Effects of Pubertal Cannabinoid Administration on Attentional Set-Shifting and Dopaminergic Hyper-Responsivity in a Developmental Disruption Model of Schizophrenia
Gomes, F. V., Guimarães, F. S., & Grace, A. A. (2015) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyu018 · Cited by 68
Non-coding RNA dysregulation in the amygdala region of schizophrenia patients contributes to the pathogenesis of the disease
Liu, Y., Chang, X., Hahn, C.-G., Gur, R. E., Abou‐Sleiman, P. M., & Hakonarson, H. H. (2018) · Translational Psychiatry · doi:10.1038/s41398-017-0030-5 · Cited by 69
Pharmacology of epigenetics in brain disorders
Narayan, P. J., & Dragunow, M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00526.x · Cited by 67
Increased diffusivity in superior temporal gyrus in patients with schizophrenia: A Diffusion Tensor Imaging study
Lee, K., Yoshida, T., Kubicki, M. R., Sylvain Bouix, A., Westin, C., Kindlmann, G., Niznikiewicz, M. A., Cohen, A. S., McCarley, R. W., & Shenton, M. E. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2008.11.024 · Cited by 67
Cortical Glutamatergic Markers in Schizophrenia
Scarr, E., Beneyto, M., Meador‐Woodruff, J. H., & Dean, B. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300758 · Cited by 67
Mechanisms of Neuregulin Action
Talmage, D. A. (2008) · Novartis Foundation symposium · doi:10.1002/9780470751251.ch6 · Cited by 67
Schizophrenia: a genetic disorder of the synapse?
Owen, M. J., O’Donovan, M. C., & Harrison, P. J. (2005) · BMJ · doi:10.1136/bmj.330.7484.158 · Cited by 67
Self-citation
Disordered corticolimbic interactions during affective processing in children and adolescents at risk for schizophrenia revealed by functional magnetic resonance imaging and dynamic causal modeling
Diwadkar, V. A. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1349 · Cited by 66
A Population-Based Study of Shared Genetic Variation Between Premorbid IQ and Psychosis Among Male Twin Pairs and Sibling Pairs From Sweden
Zammit, S. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.1370 · Cited by 64
The Neuroimmunology of Schizophrenia
Annya, M., Smyth, Stephen, M., & Lawrie, S. M. (2013) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2013.11.3.107 · Cited by 68
Transcription factor 4 (TCF4) and schizophrenia: integrating the animal and the human perspective
Quednow, B. B., Brzózka, M. M., & Rossner, M. J. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1553-4 · Cited by 65
Convergent Genomic Studies Identify Association of GRIK2 and NPAS2 with Chronic Fatigue Syndrome
Smith, A. K., Fang, H., Whistler, T., Unger, E. R., & Rajeevan, M. S. (2011) · Neuropsychobiology · doi:10.1159/000326692 · Cited by 67
Expression of a GRM3 Splice Variant is Increased in the Dorsolateral Prefrontal Cortex of Individuals Carrying a Schizophrenia Risk SNP
Sartorius, L. J., Weinberger, D. R., Hyde, T. M., Harrison, P. J., Kleinman, J. E., & Lipska, B. K. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301669 · Cited by 66
Self-citation
Presynaptic Regulation of Dopamine Transmission in Schizophrenia
Lyon, G. J., Abi‐Dargham, A., Moore, H. M., Lieberman, J. A., Javitch, J. A., & Sulzer, D. (2009) · Schizophrenia Bulletin · doi:10.1093/schbul/sbp010 · Cited by 71
Comparing Genes and Phenomenology in the Major Psychoses: Schizophrenia and Bipolar 1 Disorder
Ivleva, E. I., Thaker, G. K., & Tamminga, C. A. (2007) · Schizophrenia Bulletin · doi:10.1093/schbul/sbn051 · Cited by 66
DNA Damage in Major Psychiatric Diseases
Raza, M. U., Tufan, T., Wang, Y., Hill, C. P., & Zhu, M. (2016) · Neurotoxicity Research · doi:10.1007/s12640-016-9621-9 · Cited by 70
Neuroinflammation and glial cell activation in mental disorders
Almeida, P. G. C., Nani, J. V. S., Oses, J. P., Brietzke, E. M., & Hayashi, M. A. F. (2019) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2019.100034 · Cited by 75
Netrin‐1 receptor‐deficient mice show enhanced mesocortical dopamine transmission and blunted behavioural responses to amphetamine
Grant, A., Hoops, D., Labelle‐Dumais, C., Prévost, M., Rajabi, H., Kolb, B. E., Stewart, J., Arvanitogiannis, A., & Flores, C. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05888.x · Cited by 65
RGS4 Modulates Serotonin Signaling in Prefrontal Cortex and Links to Serotonin Dysfunction in a Rat Model of Schizophrenia
Gu, Z., Jiang, Q., & Yan, Z. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.032490 · Cited by 67
Aggregated proteins in schizophrenia and other chronic mental diseases
Korth, C. (2012) · Prion · doi:10.4161/pri.18989 · Cited by 64
Pregnenolone Rescues Schizophrenia-Like Behavior in Dopamine Transporter Knockout Mice
Wong, P., Chang, C. C. R., Marx, C. E., Caron, M. G., Wetsel, W. C., & Zhang, X. (2012) · PLoS ONE · doi:10.1371/journal.pone.0051455 · Cited by 65
Genetic and neural dissociation of individual responses to emotional expressions in human infants
Großmann, T., Johnson, M. H., Vaish, A., Hughes, D. A., Quinque, D., Stoneking, M., & Friederici, A. D. (2010) · Developmental Cognitive Neuroscience · doi:10.1016/j.dcn.2010.07.001 · Cited by 70
The early growth response protein 1-miR-30a-5p-neurogenic differentiation factor 1 axis as a novel biomarker for schizophrenia diagnosis and treatment monitoring
Liu, S., Zhang, F., Shugart, Y. Y., Yang, L., Li, X., Liu, Z., Sun, N., Yang, C., Guo, X., Shi, J., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2016.268 · Cited by 65
Analyzing Schizophrenia by DNA Microarrays
Horváth, S., Janka, Z., & Mirnics, K. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.07.017 · Cited by 64
Pathways to psychosis: Help-seeking behavior in the prodromal phase
Rietdijk, J., Hogerzeil, S. J., van Hemert, A. M., Cuijpers, P., Linszen, D. H., & van der Gaag, M. (2011) · Schizophrenia Research · doi:10.1016/j.schres.2011.08.009 · Cited by 64
Connectivity between mitochondrial functions and psychiatric disorders
Hroudová, J., & Fišar, Z. (2011) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.2010.02178.x · Cited by 63
Proof-of-concept randomized controlled trial of pregnenolone in schizophrenia
Marx, C. E., Lee, J., Subramaniam, M., Rapisarda, A., Bautista, D., Chan, E. S., Kilts, J. D., Buchanan, R. W., Eu, P. W., Verma, S. K., et al. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3673-4 · Cited by 67
Effects of the methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism on executive function in schizophrenia
Roffman, J. L., Weiss, A. P., Deckersbach, T., Freudenreich, O., Henderson, D. C., Purcell, S., Wong, D. H., Halsted, C. H., & GOFF, D. C. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.01.003 · Cited by 64
Replication of Association Between Working Memory and Reelin, a Potential Modifier Gene in Schizophrenia
Wedenoja, J., Tuulio‐Henriksson, A., Suvisaari, J., Loukola, A., Paunio, T., Partonen, T., Varilo, T., Lönnqvist, J. K., & Peltonen, L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.026 · Cited by 67
Ethnic Stratification of the Association of RGS4 Variants with Antipsychotic Treatment Response in Schizophrenia
Campbell, D. B., Ebert, P. J., Skelly, T. J., Stroup, T. S., Lieberman, J. A., Levitt, P. R., & Sullivan, P. F. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.04.018 · Cited by 63
Up‐regulation of NMDA receptor subunit and post‐synaptic density protein expression in the thalamus of elderly patients with schizophrenia
Clinton, S. M., Haroutunian, V. H., & Meador‐Woodruff, J. H. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03954.x · Cited by 64
Psychotherapy and mental health teams
Kerr, I. B., Dent‐Brown, K., & Parry, G. D. (2007) · International Review of Psychiatry · doi:10.1080/09540260601109380 · Cited by 63
The excitatory-inhibitory balance as a target for the development of novel drugs to treat schizophrenia
Uliana, D. L., Lisboa, J. R., Gomes, F. V., & Grace, A. A. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116298 · Cited by 71
Neuregulin-1 Regulates Cell Adhesion via an ErbB2/Phosphoinositide-3 Kinase/Akt-Dependent Pathway: Potential Implications for Schizophrenia and Cancer
Kanakry, C. G., Li, Z., Nakai, Y., Sei, Y., & Weinberger, D. R. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001369 · Cited by 63
Self-citation
Genetic Counseling in Psychiatry
Finn, C. T., & Smoller, J. W. (2006) · Harvard Review of Psychiatry · doi:10.1080/10673220600655723 · Cited by 63
Association between the DTNBP1 gene and intelligence: a case-control study in young patients with schizophrenia and related disorders and unaffected siblings
Zinkstok, J., Wilde, O. B.-D., van Amelsvoort, T., Tanck, M. W. T., Baas, F., & LINSZEN, D. H. (2007) · Behavioral and Brain Functions · doi:10.1186/1744-9081-3-19 · Cited by 62
Altered dopaminergic pathways and therapeutic effects of intranasal dopamine in two distinct mouse models of autism
Chao, O. Y.-H., Pathak, S. S., Zhang, H., Dunaway, N., Li, J., Mattern, C., Nikolaus, S., Huston, J. P., & Yang, Y. (2020) · Molecular Brain · doi:10.1186/s13041-020-00649-7 · Cited by 62
PLC‐β1 knockout mice as a model of disrupted cortical development and plasticity: Behavioral endophenotypes and dysregulation of RGS4 gene expression
McOmish, C. E., Burrows, E. L., Howard, M. L., & Hannan, A. J. (2008) · Hippocampus · doi:10.1002/hipo.20443 · Cited by 60
Clinical and genetic high-risk strategies in understanding vulnerability to psychosis
Cannon, T. D. (2005) · Schizophrenia Research · doi:10.1016/j.schres.2005.06.014 · Cited by 65
Metabolic abnormalities in fronto-striatal-thalamic white matter tracts in schizophrenia
Beasley, C. L., Dwork, A. J., Rosoklija, G. B., Mann, J. J., Mancevski, B., Jakovski, Z., Davceva, N., Tait, A. R., Straus, S. K., & Honer, W. G. (2009) · Schizophrenia Research · doi:10.1016/j.schres.2009.01.017 · Cited by 62
Inhibitors of GlyT1 Affect Glycine Transport via Discrete Binding Sites
Mezler, M., Hornberger, W., Mueller, R., Schmidt, M. U., Amberg, W., Braje, W. M., Ochse, M., Schoemaker, H., & Behl, B. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.049312 · Cited by 62
In Utero Electroporation as a Tool For Genetic Manipulation In Vivo to Study Psychiatric Disorders
Taniguchi, Y., Young‐Pearse, T. L., Sawa, A., & Kamiya, A. (2011) · The Neuroscientist · doi:10.1177/1073858411399925 · Cited by 62
Long homopurine*homopyrimidine sequences are characteristic of genes expressed in brain and the pseudoautosomal region
Bacolla, A., Collins, J., Gold, B., Chuzhanova, N. A., Yi, M., Stephens, R. M., Stefanov, S. A., Olsh, A., Jakupciak, J. P., Dean, M. C., et al. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkl354 · Cited by 62
Adaptive sparse multiple canonical correlation analysis with application to imaging (epi)genomics study of schizophrenia
Hu, W., Lin, D., Cao, S., Liu, J., Chen, J., Calhoun, V. D., & Wang, Y. (2017) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2017.2771483 · Cited by 62
Combination of prenatal immune challenge and restraint stress affects prepulse inhibition and dopaminergic/GABAergic markers
Deslauriers, J., Larouche, A., Sarret, P., & Grignon, S. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.05.006 · Cited by 63
Group II metabotropic glutamate receptors and schizophrenia
Moreno, J. L., Sealfon, S. C., & González‐Maeso, J. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-0130-3 · Cited by 61
Thyroid hormones and retinoids: A possible link between genes and environment in schizophrenia
Palha, J. A., & Goodman, A. B. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.10.001 · Cited by 61
Disrupted-in-Schizophrenia-1 (Disc1) is necessary for migration of the pyramidal neurons during mouse hippocampal development
Tomita, K., Kubo, K., Ishii, K., & Nakajima, K. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr194 · Cited by 61
Phosphodiesterase Inhibition and Regulation of Dopaminergic Frontal and Striatal Functioning: Clinical Implications
Heckman, P. R. A., van Duinen, M. A., Bollen, E., Nishi, A., Wennogle, L. P., Blokland, A., & Prickaerts, J. (2016) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyw030 · Cited by 63
Group II Metabotropic Glutamate Receptors as Targets for Novel Antipsychotic Drugs
Muguruza, C., Meana, J. J., & Callado, L. F. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00130 · Cited by 61
Proteomic analysis of the postsynaptic density implicates synaptic function and energy pathways in bipolar disorder
Föcking, M., Dicker, P., Lopez, L. M., Hryniewiecka, M., Wynne, K. J., English, J. A., Cagney, G., & Cotter, D. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.224 · Cited by 61
The genetics of schizophrenia
Bertolino, A., & Blasi, G. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.04.038 · Cited by 63
Altered Expression Profile of IgLON Family of Neural Cell Adhesion Molecules in the Dorsolateral Prefrontal Cortex of Schizophrenic Patients
Karis, K., Eskla, K., Kaare, M., Täht, K., Tuusov, J., Visnapuu, T., Innos, J., Jayaram, M., Timmusk, T., Weickert, C. S., et al. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00008 · Cited by 60
GRIN2A (NR2A): a gene contributing to glutamatergic involvement in schizophrenia
Harrison, P. J., & Bannerman, D. M. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02265-y · Cited by 57
Self-citation
Genetic Association Studies of Antioxidant Pathway Genes and Schizophrenia
Chowdari, K. V., Bamne, M. N., & Nimgaonkar, V. L. (2010) · Antioxidants and Redox Signaling · doi:10.1089/ars.2010.3508 · Cited by 60
BDNF mediates the neuroprotective effects of positive AMPA receptor modulators against MPP+-induced toxicity in cultured hippocampal and mesencephalic slices
Jourdi, H., Hamo, L., Oka, T., Seegan, A., & Baudry, M. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2009.01.015 · Cited by 60
Glutamatergic antipsychotic drugs: a new dawn in the treatment of schizophrenia?
Stone, J. M. (2011) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125311400779 · Cited by 60
Measurement and comparison of serum neuregulin 1 immunoreactivity in control subjects and patients with schizophrenia: an influence of its genetic polymorphism
Shibuya, M., Komi, E., Wang, R., Kato, T., Watanabe, Y., Sakai, M., Ozaki, M., Someya, T., & Nawa, H. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0418-3 · Cited by 60
Genetic causality in schizophrenia and bipolar disorder: out with the old and in with the new
Porteous, D. J. (2008) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.07.005 · Cited by 60
Deep learning based automatic diagnosis of first-episode psychosis, bipolar disorder and healthy controls
Li, Z., Li, W., Wei, Y., Gui, G., Zhang, R., Liu, H., Chen, Y., & Jiang, Y. (2021) · Computerized Medical Imaging and Graphics · doi:10.1016/j.compmedimag.2021.101882 · Cited by 59
Laminar and Dorsoventral Molecular Organization of the Medial Entorhinal Cortex Revealed by Large-scale Anatomical Analysis of Gene Expression
Ramsden, H. L., Sürmeli, G., McDonagh, S., & Nolan, M. F. (2015) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004032 · Cited by 63
Dopamine D4 Receptor Activation Increases Hippocampal Gamma Oscillations by Enhancing Synchronization of Fast-Spiking Interneurons
Andersson, R., Johnston, A. D., & Fisahn, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0040906 · Cited by 58
Postsynaptic density levels of the NMDA receptor NR1 subunit and PSD-95 protein in prefrontal cortex from people with schizophrenia
Catts, V. S., Derminio, D. S., Hahn, C.-G., & Weickert, C. S. (2015) · npj Schizophrenia · doi:10.1038/npjschz.2015.37 · Cited by 58
Catechol-O-methyltransferase Val158Met polymorphism associates with individual differences in sleep physiologic responses to chronic sleep loss
Goel, N., Banks, S., Lin, L., Mignot, E., & Dinges, D. F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0029283 · Cited by 58
Early trauma and familial risk in the development of the extended psychosis phenotype in adolescence
Wigman, J. T. W., van Winkel, R., Ormel, J., Verhulst, F. C., van Os, J., & Vollebergh, W. (2012) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2012.01857.x · Cited by 58
Progressive pathology is functionally linked to the domains of language and emotion: meta-analysis of brain structure changes in schizophrenia patients
Nickl‐Jockschat, T., Schneider, F. W., Pagel, A. D., Laird, A. R., Fox, P. T., & Eickhoff, S. B. (2011) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-011-0249-8 · Cited by 61
Increased SNARE Protein-Protein Interactions in Orbitofrontal and Anterior Cingulate Cortices in Schizophrenia
Ramos‐Miguel, A., Beasley, C. L., Dwork, A. J., Mann, J. J., Rosoklija, G. B., Barr, A. M., & Honer, W. G. (2014) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.12.012 · Cited by 58
Combined study of genetic and epigenetic biomarker risperidone treatment efficacy in Chinese Han schizophrenia patients
Shi, Y., Li, M., Song, C., Xu, Q., Huo, R., Shen, L., Xing, Q., Cui, D., Li, W., Zhao, J., et al. (2017) · Translational Psychiatry · doi:10.1038/tp.2017.143 · Cited by 58
Effect of antipsychotic drugs on DISC1 and dysbindin expression in mouse frontal cortex and hippocampus
Chiba, S., Hashimoto, R., Hattori, S., Yohda, M., Lipska, B. K., Weinberger, D. R., & Kunugi, H. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-005-0414-1 · Cited by 58
Self-citation
Genetics of clinical features and subtypes of schizophrenia: A review of the recent literature
Fanous, A. H., & Kendler, K. S. (2008) · Current Psychiatry Reports · doi:10.1007/s11920-008-0028-z · Cited by 57
Hippocampal Neuroligin-2 Overexpression Leads to Reduced Aggression and Inhibited Novelty Reactivity in Rats
Kohl, C., Riccio, O., Grosse, J., Zanoletti, O., Fournier, C., Schmidt, M. V., & Sandi, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056871 · Cited by 59
The calcium-sensitive Sigma-1 receptor prevents cannabinoids from provoking glutamate NMDA receptor hypofunction: implications in antinociception and psychotic diseases
Sánchez‐Blázquez, P., Rodríguez-Muñoz, M., Herrero-Labrador, R., Burgueño, J., Zamanillo, D., & Garzón, J. (2014) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145714000029 · Cited by 57
The catechol-O-methyltransferase Val158Met polymorphism modulates fronto-cortical dopamine turnover in early Parkinson’s disease: a PET study
Wu, K., O’Keeffe, D., Politis, M., O’Keeffe, G. C., Robbins, T. W., Bose, S. K., Brooks, D. J., Piccini, P. P., & Barker, R. A. (2012) · Brain · doi:10.1093/brain/aws157 · Cited by 59
Altered hippocampal expression of glutamate receptors and transporters in GRM2 and GRM3 knockout mice
Lyon, L., Kew, J. N. C., Corti, C., Harrison, P. J., & Burnet, P. W. J. (2008) · Synapse · doi:10.1002/syn.20553 · Cited by 57
Self-citation
Mice mutant for genes associated with schizophrenia: Common phenotype or distinct endophenotypes?
Desbonnet, L., Waddington, J. L., & O’Tuathaigh, C. M. P. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.04.001 · Cited by 57
Do apparent overlaps between schizophrenia and autistic spectrum disorders reflect superficial similarities or etiological commonalities?
Stone, W. S., & Iguchi, L. (2011) · North American Journal of Medicine and Science · doi:10.7156/v4i3p124 · Cited by 57
COMT , BDNF , and DTNBP1 polymorphisms and cognitive functions in patients with brain tumors
Correa, D. D., Satagopan, J. M., Cheung, K., Arora, A., Kryza‐Lacombe, M., Xu, Y., Karimi, S., Lyo, J. K., DeAngelis, L. M., & Orlow, I. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now057 · Cited by 57
Dysbindin-1 and Its Protein Family
Talbot, K., Ong, W., Blake, D. J., Tang, J., Louneva, N., Carlson, G. C., & Arnold, S. E. (2009) · Springer eBooks · doi:10.1007/978-0-387-30410-6_5 · Cited by 57
Neuregulin-2 ablation results in dopamine dysregulation and severe behavioral phenotypes relevant to psychiatric disorders
Yan, L.-Q., Shamir, A., Skirzewski, M., Leiva‐Salcedo, E., Kwon, O., Karavanova, I. D., Paredes, D., Malkesman, O., Bailey, K. R., Vullhorst, D., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.22 · Cited by 59
Effect of ligand binding on human D ‐amino acid oxidase: Implications for the development of new drugs for schizophrenia treatment
Caldinelli, L., Molla, G., Bracci, L., Lelli, B., Pileri, S., Cappelletti, P., Sacchi, S., & Pollegioni, L. (2010) · Protein Science · doi:10.1002/pro.429 · Cited by 57
No evidence for association between polymorphisms in GRM3and schizophrenia
Norton, N., Williams, H. J., Dwyer, S., Ivanov, D. K., Preece, A. C., Gerrish, A., Williams, N. M., Yerassimou, P., Zammit, S., O’Donovan, M. C., et al. (2005) · BMC Psychiatry · doi:10.1186/1471-244x-5-23 · Cited by 57
Cilia interactome with predicted protein-protein interactions reveals connections to Alzheimer’s disease, aging and other neuropsychiatric processes
Karunakaran, K. B., Chaparala, S., Lo, C. W., & Ganapathiraju, M. K. (2020) · Scientific Reports · doi:10.1038/s41598-020-72024-4 · Cited by 56
Phencyclidine and Dizocilpine Induced Behaviors Reduced by N-acetylaspartylglutamate Peptidase Inhibition via Metabotropic Glutamate Receptors
Olszewski, R. T., Wegorzewska, M. M., Monteiro, A. C., Krolikowski, K. A., Zhou, J., Kozikowski, A. P., Long, K. D., Mastropaolo, J. P., Deutsch, S. I., & Neale, J. H. (2007) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.04.016 · Cited by 56
Mutant models for genes associated with schizophrenia
Desbonnet, L., Waddington, J. L., & O’Tuathaigh, C. M. P. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370308 · Cited by 57
Background Dopamine Concentration Dependently Facilitates Long-term Potentiation in Rat Prefrontal Cortex through Postsynaptic Activation of Extracellular Signal-Regulated Kinases
Kolomiets, B. P., Marzo, A., Caboche, J., Vanhoutte, P., & Otani, S. (2009) · Cerebral Cortex · doi:10.1093/cercor/bhp047 · Cited by 56
Chronic haloperidol treatment results in a decrease in the expression of myelin/oligodendrocyte‐related genes in the mouse brain
Narayan, S., Kass, K. E., & Thomas, E. A. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.21161 · Cited by 56
Strong preferences of dopamine and l ‐dopa towards lipid head group: importance of lipid composition and implication for neurotransmitter metabolism
Orłowski, A., Grzybek, M., Bunker, A., Pasenkiewicz‐Gierula, M., Vattulainen, I., Männistö, P. T., & Róg, T. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07813.x · Cited by 55
Schizophrenia susceptibility gene dysbindin regulates glutamatergic and dopaminergic functions via distinctive mechanisms in Drosophila
Shao, L., Shuai, Y., Wang, J., Feng, S., Lu, B., Li, Z., Zhao, Y., Wang, L., & Zhong, Y. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114569108 · Cited by 55
The Wnt Pathway in Mood Disorders
Sani, G., Napoletano, F., Forte, A. M., Kotzalidis, G. D., Panaccione, I., Porfiri, G. M., Simonetti, A., Caloro, M., Girardi, N., Telesforo, C. L., et al. (2012) · Current Neuropharmacology · doi:10.2174/157015912803217279 · Cited by 59
Systematic Integration of Brain eQTL and GWAS IdentifiesZNF323as a Novel Schizophrenia Risk Gene and Suggests Recent Positive Selection Based on Compensatory Advantage on Pulmonary Function
Luo, X., Mattheisen, M., Li, M., Huang, L., Rietschel, M., Børglum, A. D., Als, T. D., van den Oord, E. J. C. G., Åberg, K. A., Mors, O. N., et al. (2015) · Schizophrenia Bulletin · doi:10.1093/schbul/sbv017 · Cited by 54
Altered Hippocampal-Parahippocampal Function During Stimulus Encoding
Rasetti, R., Mattay, V. S., White, M. G., Sambataro, F., Podell, J. E., Zoltick, B. J., Chen, Q., Berman, K. F., Callicott, J. H., & Weinberger, D. R. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2013.3911 · Cited by 55
Self-citation

Authors: Harrison, P. J., & Weinberger, D. R.
Affiliations: Warneford Hospital (GB)
National Institutes of Health (US)
ORCID: Harrison, P J
Weinberger, D R
Venue: Molecular Psychiatry
Publisher: Springer Science and Business Media LLC
Published: 2004-07-20
Volume: 10
Issue: 1
Pages: 40-68
ISSN: 1359-4184 (ISSN-L)
1476-5578
DOI: 10.1038/sj.mp.4001558
OpenAlex: W2071090720
Cited by: 2,020
References: 399
Citations by year: 2026: 10 · 2025: 20 · 2024: 22 · 2023: 38 · 2022: 38 · 2021: 34 · 2020: 34 · 2019: 42 · 2018: 52 · 2017: 58 · 2016: 66 · 2015: 88 · 2014: 102 · 2013: 92 · 2012: 129
FWCI: 22.22
Type: journal article
Language: en
Update notices: erratum (2005-03-29)
Open access: closed
Licence: www.springer.com/tdm (tdm)
www.springer.com/tdm (vor)
Locations: Molecular Psychiatry (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Social Sciences › Arts and Humanities › Philosophy › Mental Health and Psychiatry
Keywords: schizophrenia, schizophrenia genetics, susceptibility genes, gene expression, synaptic plasticity, cortical microcircuitry, NMDA receptor, glutamatergic neurotransmission, dopamine signalling, GABA signalling, neuregulin, dysbindin, catechol-O-methyltransferase, DISC1, RGS4, GRM3, G72, hippocampus, dorsolateral prefrontal cortex, dorsal thalamus, brain connectivity
MeSH terms: Dysbindin, Brain, Carrier Proteins, Catechol O-Methyltransferase, Gene Expression Regulation, Humans, Schizophrenia, Genetic Predisposition to Disease, Neuregulin-1, Dystrophin-Associated Proteins

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks